These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11282107)

  • 21. Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians.
    Zhao J; Duprè N; Puymirat J; Chahine M
    J Physiol; 2012 Jun; 590(11):2629-44. PubMed ID: 22250216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.
    Desaphy JF; De Luca A; Tortorella P; De Vito D; George AL; Conte Camerino D
    Neurology; 2001 Nov; 57(10):1849-57. PubMed ID: 11723275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoform-specific lidocaine block of sodium channels explained by differences in gating.
    Nuss HB; Kambouris NG; Marbán E; Tomaselli GF; Balser JR
    Biophys J; 2000 Jan; 78(1):200-10. PubMed ID: 10620286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants.
    El-Bizri N; Kahlig KM; Shyrock JC; George AL; Belardinelli L; Rajamani S
    Channels (Austin); 2011; 5(2):161-72. PubMed ID: 21317558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of local anesthetics on Na+ channels containing the equine hyperkalemic periodic paralysis mutation.
    Sah RL; Tsushima RG; Backx PH
    Am J Physiol; 1998 Aug; 275(2):C389-400. PubMed ID: 9688593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line.
    Fan Z; George AL; Kyle JW; Makielski JC
    J Physiol; 1996 Oct; 496 ( Pt 1)(Pt 1):275-86. PubMed ID: 8910215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues.
    Haeseler G; Karst M; Foadi N; Gudehus S; Roeder A; Hecker H; Dengler R; Leuwer M
    Br J Pharmacol; 2008 Sep; 155(2):265-75. PubMed ID: 18574460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation-deficient human skeletal muscle Na+ channels (hNav1.4-L443C/A444W) in stably transfected HEK-293 cells.
    Wang SY; Moczydlowski E; Wang G
    Recept Channels; 2004; 10(3-4):131-8. PubMed ID: 15512848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural features of phenol derivatives determining potency for activation of chloride currents via alpha(1) homomeric and alpha(1)beta heteromeric glycine receptors.
    Haeseler G; Ahrens J; Krampfl K; Bufler J; Dengler R; Hecker H; Aronson JK; Leuwer M
    Br J Pharmacol; 2005 Aug; 145(7):916-25. PubMed ID: 15912136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac sodium channels (hH1) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (mu 1) channels.
    Nuss HB; Tomaselli GF; Marbán E
    J Gen Physiol; 1995 Dec; 106(6):1193-209. PubMed ID: 8786356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An improved model for the binding of lidocaine and structurally related local anaesthetics to fast-inactivated voltage-operated sodium channels, showing evidence of cooperativity.
    Leuwer M; Haeseler G; Hecker H; Bufler J; Dengler R; Aronson JK
    Br J Pharmacol; 2004 Jan; 141(1):47-54. PubMed ID: 14662728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External pore residue mediates slow inactivation in mu 1 rat skeletal muscle sodium channels.
    Balser JR; Nuss HB; Chiamvimonvat N; Pérez-García MT; Marban E; Tomaselli GF
    J Physiol; 1996 Jul; 494 ( Pt 2)(Pt 2):431-42. PubMed ID: 8842002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential block of inactivation-deficient Na+ currents by capsaicin reveals a non-TRPV1 receptor within the Na+ channel.
    Wang SY; Mitchell J; Wang GK
    Pain; 2007 Jan; 127(1-2):73-83. PubMed ID: 16962240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective slow inactivation of sodium channels contributes to familial periodic paralysis.
    Hayward LJ; Sandoval GM; Cannon SC
    Neurology; 1999 Apr; 52(7):1447-53. PubMed ID: 10227633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coupling between fast and slow inactivation revealed by analysis of a point mutation (F1304Q) in mu 1 rat skeletal muscle sodium channels.
    Nuss HB; Balser JR; Orias DW; Lawrence JH; Tomaselli GF; Marban E
    J Physiol; 1996 Jul; 494 ( Pt 2)(Pt 2):411-29. PubMed ID: 8842001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State-dependent block of wild-type and inactivation-deficient Na+ channels by flecainide.
    Wang GK; Russell C; Wang SY
    J Gen Physiol; 2003 Sep; 122(3):365-74. PubMed ID: 12913091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A C-terminal skeletal muscle sodium channel mutation associated with myotonia disrupts fast inactivation.
    Wu FF; Gordon E; Hoffman EP; Cannon SC
    J Physiol; 2005 Jun; 565(Pt 2):371-80. PubMed ID: 15774523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Block of inactivation-deficient Na+ channels by local anesthetics in stably transfected mammalian cells: evidence for drug binding along the activation pathway.
    Wang SY; Mitchell J; Moczydlowski E; Wang GK
    J Gen Physiol; 2004 Dec; 124(6):691-701. PubMed ID: 15545401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium channel isoform-specific effects of halothane: protein kinase C co-expression and slow inactivation gating.
    Patel MK; Mistry D; John JE; Mounsey JP
    Br J Pharmacol; 2000 Aug; 130(8):1785-92. PubMed ID: 10952666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic link between lidocaine block and inactivation probed by outer pore mutations in the rat micro1 skeletal muscle sodium channel.
    Kambouris NG; Hastings LA; Stepanovic S; Marban E; Tomaselli GF; Balser JR
    J Physiol; 1998 Nov; 512 ( Pt 3)(Pt 3):693-705. PubMed ID: 9769414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.